FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4221094025> ?p ?o ?g. }

• W4221094025 endingPage "2549" @default.
• W4221094025 startingPage "2539" @default.
• W4221094025 abstract "Because mammalian cardiomyocytes largely cease to proliferate immediately after birth, the regenerative activity of the heart is limited. To date, much effort has been made to clarify the regulatory mechanism of cardiomyocyte proliferation because the amplification of cardiomyocytes could be a promising strategy for heart regenerative therapy. Recently, it was reported that the inhibition of glycogen synthase kinase (GSK)-3 promotes the proliferation of neonatal rat cardiomyocytes (NRCMs) and human iPS cell-derived cardiomyocytes (hiPSC-CMs). Additionally, Yes-associated protein (YAP) induces cardiomyocyte proliferation. The purpose of this study was to address the importance of YAP activity in cardiomyocyte proliferation induced by GSK-3 inhibitors (GSK-3Is) to develop a novel strategy for cardiomyocyte amplification. Immunofluorescent microscopic analysis using an anti-Ki-67 antibody demonstrated that the treatment of NRCMs with GSK-3Is, such as BIO and CHIR99021, increased the ratio of proliferative cardiomyocytes. YAP was localized in the nuclei of more than 95% of cardiomyocytes, either in the presence or absence of GSK-3Is, indicating that YAP was endogenously activated. GSK-3Is increased the expression of β-catenin and promoted its translocation into the nucleus without influencing YAP activity. The knockdown of YAP using siRNA or pharmacological inhibition of YAP using verteporfin or CIL56 dramatically reduced GSK-3I-induced cardiomyocyte proliferation without suppressing β-catenin activation. Interestingly, the inhibition of GSK-3 also induced the proliferation of hiPSC-CMs under sparse culture conditions, where YAP was constitutively activated. In contrast, under dense culture conditions, in which YAP activity was suppressed, the proliferative effects of GSK-3Is on hiPSC-CMs were not detected. Importantly, the activation of YAP by the knockdown of α-catenin restored the proproliferative activity of GSK-3Is. Collectively, YAP activation potentiates the GSK-3I-induced proliferation of cardiomyocytes. The blockade of GSK-3 in combination with YAP activation resulted in remarkable amplification of cardiomyocytes." @default.
• W4221094025 created "2022-04-03" @default.
• W4221094025 creator A5007350512 @default.
• W4221094025 creator A5014423509 @default.
• W4221094025 creator A5015992381 @default.
• W4221094025 creator A5035680064 @default.
• W4221094025 creator A5045168236 @default.
• W4221094025 creator A5048208111 @default.
• W4221094025 creator A5060351509 @default.
• W4221094025 creator A5067114079 @default.
• W4221094025 creator A5071017138 @default.
• W4221094025 creator A5079504532 @default.
• W4221094025 creator A5088394345 @default.
• W4221094025 creator A5091784274 @default.
• W4221094025 date "2022-03-21" @default.
• W4221094025 modified "2023-10-14" @default.
• W4221094025 title "Yes‐associated protein activation potentiates glycogen synthase kinase‐3 inhibitor‐induced proliferation of neonatal cardiomyocytes and iPS cell‐derived cardiomyocytes" @default.
• W4221094025 cites W1669479280 @default.
• W4221094025 cites W1978173381 @default.
• W4221094025 cites W1996435746 @default.
• W4221094025 cites W2009682316 @default.
• W4221094025 cites W2017770112 @default.
• W4221094025 cites W2038313908 @default.
• W4221094025 cites W2071765960 @default.
• W4221094025 cites W2075528452 @default.
• W4221094025 cites W2099709490 @default.
• W4221094025 cites W2099793239 @default.
• W4221094025 cites W2109439508 @default.
• W4221094025 cites W2121072573 @default.
• W4221094025 cites W2129466238 @default.
• W4221094025 cites W2141595533 @default.
• W4221094025 cites W2337681077 @default.
• W4221094025 cites W2607900874 @default.
• W4221094025 cites W2754548624 @default.
• W4221094025 cites W2788256001 @default.
• W4221094025 cites W2806874379 @default.
• W4221094025 cites W2896040183 @default.
• W4221094025 cites W2896353762 @default.
• W4221094025 cites W3040598213 @default.
• W4221094025 cites W3096345853 @default.
• W4221094025 cites W3143375899 @default.
• W4221094025 cites W3165046225 @default.
• W4221094025 cites W4221094025 @default.
• W4221094025 doi "https://doi.org/10.1002/jcp.30724" @default.
• W4221094025 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35312066" @default.
• W4221094025 hasPublicationYear "2022" @default.
• W4221094025 type Work @default.
• W4221094025 citedByCount "5" @default.
• W4221094025 countsByYear W42210940252022 @default.
• W4221094025 countsByYear W42210940252023 @default.
• W4221094025 crossrefType "journal-article" @default.
• W4221094025 hasAuthorship W4221094025A5007350512 @default.
• W4221094025 hasAuthorship W4221094025A5014423509 @default.
• W4221094025 hasAuthorship W4221094025A5015992381 @default.
• W4221094025 hasAuthorship W4221094025A5035680064 @default.
• W4221094025 hasAuthorship W4221094025A5045168236 @default.
• W4221094025 hasAuthorship W4221094025A5048208111 @default.
• W4221094025 hasAuthorship W4221094025A5060351509 @default.
• W4221094025 hasAuthorship W4221094025A5067114079 @default.
• W4221094025 hasAuthorship W4221094025A5071017138 @default.
• W4221094025 hasAuthorship W4221094025A5079504532 @default.
• W4221094025 hasAuthorship W4221094025A5088394345 @default.
• W4221094025 hasAuthorship W4221094025A5091784274 @default.
• W4221094025 hasBestOaLocation W42210940251 @default.
• W4221094025 hasConcept C104629339 @default.
• W4221094025 hasConcept C11960822 @default.
• W4221094025 hasConcept C173396325 @default.
• W4221094025 hasConcept C182996813 @default.
• W4221094025 hasConcept C184235292 @default.
• W4221094025 hasConcept C185592680 @default.
• W4221094025 hasConcept C190283241 @default.
• W4221094025 hasConcept C192118531 @default.
• W4221094025 hasConcept C207200792 @default.
• W4221094025 hasConcept C55493867 @default.
• W4221094025 hasConcept C62112901 @default.
• W4221094025 hasConcept C86803240 @default.
• W4221094025 hasConcept C95444343 @default.
• W4221094025 hasConceptScore W4221094025C104629339 @default.
• W4221094025 hasConceptScore W4221094025C11960822 @default.
• W4221094025 hasConceptScore W4221094025C173396325 @default.
• W4221094025 hasConceptScore W4221094025C182996813 @default.
• W4221094025 hasConceptScore W4221094025C184235292 @default.
• W4221094025 hasConceptScore W4221094025C185592680 @default.
• W4221094025 hasConceptScore W4221094025C190283241 @default.
• W4221094025 hasConceptScore W4221094025C192118531 @default.
• W4221094025 hasConceptScore W4221094025C207200792 @default.
• W4221094025 hasConceptScore W4221094025C55493867 @default.
• W4221094025 hasConceptScore W4221094025C62112901 @default.
• W4221094025 hasConceptScore W4221094025C86803240 @default.
• W4221094025 hasConceptScore W4221094025C95444343 @default.
• W4221094025 hasFunder F4320311405 @default.
• W4221094025 hasFunder F4320320912 @default.
• W4221094025 hasIssue "5" @default.
• W4221094025 hasLocation W42210940251 @default.
• W4221094025 hasLocation W42210940252 @default.
• W4221094025 hasLocation W42210940253 @default.
• W4221094025 hasOpenAccess W4221094025 @default.
• W4221094025 hasPrimaryLocation W42210940251 @default.

• next